More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel full for ...

Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...

Ozempic and other weight loss drugs make you lose muscle, too. Here's why that's not as bad as it sounds, but you should ...

Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

Focus Beyond GLP-1 Therapies: While glucagon-like peptide 1 (GLP-1)-based treatments are a cornerstone for managing cardiometabolic diseases, expanding innovation to address unmet needs remains ...

While surgery has a low risk for complications, when they do occur, they are serious. This may explain why only 5%-10% of ...

The rise of weight loss drugs is not only changing individual lives, but also reshaping large sections of the economy.

Ozempic has gained widespread popularity because of its ability to promote quick weight loss. Now, it also has a lot of ...